Crosslinking of spinal cord neurofilament proteins induced by 2,5- hexanedione (110134) (25HD) was studied in rats. Male Sprague- Dawley-rats were administered 0.5% 25HD in their drinking water for 180 days. Rats were then killed and the spinal cords were removed. The neurofilament proteins were isolated and examined by sodium- dodecyl-sulfate polyacrylamide gel electrophoresis. 25HD caused significant decreases in the amounts of proteins having molecular weights of 70, 160, and 210 kilodaltons (kDa). Bands migrating at 58, 138, and 260kDa were also detected. These proteins were not found in control animals. The loss of the 70, 160, and 210kDa proteins and the appearance of new protein bands suggested that the 138 and 260kDa bands were formed as a result of crosslinking. The protein bands were examined by an immunoblotting technique using antibodies raised against the 70, 160, and 210kDa proteins. Significant immunoreactivity involving high molecular weight proteins was seen to the 70, 160, and 210kDa bands. The 138kDa protein reacted with the anti 160kDa antibody. A significant decrease in immunoreactive breakdown proteins, most evident with the 70kDa protein, was seen in the neurofilament protein preparations from the 25HD animals, but not the controls. The authors conclude that significant evidence for in-vivo crosslinking of neurofilament proteins in 25HD treated rats has been found. This suggests that protein crosslinking plays a role in 25HD induced neuropathy.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.